FIELD: medicine. SUBSTANCE: invention relates to method of screening the therapeutical useful compound eliciting active as non-competitive antagonist of receptor-regulated calcium channel. Proposed method ensures to detect novel compounds and enhance effectiveness of treatment due to reduction of numbers of by-side effects. Invention can be used as neuroprotective, anticonvulsant agents and tranquilizers. EFFECT: valuable medicinal properties of compounds. 18 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ARYLALKYLAMINES, COMPOSITIONS, METHODS OF TREATMENT AND DIAGNOSIS, METHOD OF IDENTIFICATION OF COMPOUND | 1992 |
|
RU2147574C1 |
| COMPOUNDS SHOWING ACTIVITY WITH RESPECT TO CALCIUM RECEPTORS (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT (VERSIONS) | 1995 |
|
RU2195446C2 |
| COMPOUNDS BEING ACTIVE AT A NEW SITE UPON RECEPTOR-OPERATED CALCIUM CANALS APPLIED FOR TREATING NEUROLOGICAL DISORDERS | 1996 |
|
RU2246300C2 |
| PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY WITH RESPECT TO CALCIUM RECEPTOR, METHOD OF PATIENT TREATMENT, METHOD OF ANALYSIS OF COMPOUND EXHIBITING EFFECT ON ACTIVITY OF INORGANIC ION RECEPTOR, RECEPTOR-ENCODING NUCLEIC ACID, CALCIUM RECEPTOR | 1993 |
|
RU2146132C1 |
| MONOCYCLIC L-NUCLEOSIDES, THEIR ANALOGUES AND USING | 1997 |
|
RU2188828C2 |
| PURINE L-NUCLEOSIDES, THEIR ANALOGUES AND USING | 1997 |
|
RU2183639C2 |
| POLYPEPTIDE DERIVATIVES, METHOD OF CALCIUM CHANNEL INHIBITION | 1993 |
|
RU2120945C1 |
| POLYPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2104286C1 |
| POLYPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT (VARIANTS); METHOD TO SUPPRESS THE ACTION OF AMINO ACID NEUROMEDIATORS | 1993 |
|
RU2106358C1 |
| RETINOID COMPOUNDS (VARIANTS), COMPOSITION, METHOD FOR ASSAY OF RETINOID HORMONE ANTAGONISTS, METHOD OF TREATMENT AND INTERMEDIATE SUBSTANCES | 1996 |
|
RU2203884C2 |
